Dexmedetomidine Improves the Surgical Field and Postoperative Recovery of Nasal Endoscopic Surgery
Status:
Completed
Trial end date:
2020-03-10
Target enrollment:
Participant gender:
Summary
Studies showed dexmedetomidine (DEX) could improve surgical field, but the effect for
functional nasal endoscopic surgery (FESS) was unclear. The investigators explored IV
administration of a single loading dose DEX (0.5μg/kg) for FESS, and IV administration of
midazolam (0.05mg/kg) as a control with comparision of surgical field, haemodynamics,
ventilation parameters and recovery.